Genetic variation in glutamatergic genes moderates the effects of childhood adversity on brain volume and IQ in treatment-resistant schizophrenia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Genetic variation in glutamatergic genes moderates the effects of childhood adversity on brain volume and IQ in treatment-resistant schizophrenia ; volume:9 ; number:1 ; day:14 ; month:9 ; year:2023 ; pages:1-8 ; date:12.2023
Schizophrenia ; 9, Heft 1 (14.9.2023), 1-8, 12.2023
- Creator
-
Mohamed Saini, Suriati
Bousman, Chad A.
Mancuso, Serafino G.
Cropley, Vanessa
Rheenen, Tamsyn E. Van
Lenroot, Rhoshel K.
Bruggemann, Jason
Weickert, Cynthia S.
Weickert, Thomas W.
Sundram, Suresh
Everall, Ian P.
Pantelis, Christos
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41537-023-00381-w
- URN
-
urn:nbn:de:101:1-2024020613123411506454
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mohamed Saini, Suriati
- Bousman, Chad A.
- Mancuso, Serafino G.
- Cropley, Vanessa
- Rheenen, Tamsyn E. Van
- Lenroot, Rhoshel K.
- Bruggemann, Jason
- Weickert, Cynthia S.
- Weickert, Thomas W.
- Sundram, Suresh
- Everall, Ian P.
- Pantelis, Christos
- SpringerLink (Online service)
Other Objects (12)
Glutamatergic dysfunction in Schizophrenia
Remission of severe, treatment-resistant schizophrenia following adjunctive cannabidiol
Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review
GRIN2A (NR2A): a gene contributing to glutamatergic involvement in schizophrenia
Decreased prefrontal glutamatergic function is associated with a reduced astrocyte-related gene expression in treatment-resistant depression
Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain
Targeting Treatment-Resistant Auditory Verbal Hallucinations in Schizophrenia with fMRI-Based Neurofeedback - Exploring Different Cases of Schizophrenia
Robustness osa neurodevelopmental animal model of schizophrenia : combining immune stimulation with glutamatergic insult
Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism
Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia
Treatment-resistant schizophrenia and global cortical atrophy in a patient with Turner Syndrome [Letter]
Robustness of a neurodevelopmental animal model of schizophrenia: combining immune stimulation with glutamatergic insult
Glutamatergic dysfunction in Schizophrenia
Remission of severe, treatment-resistant schizophrenia following adjunctive cannabidiol
Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review
GRIN2A (NR2A): a gene contributing to glutamatergic involvement in schizophrenia
Decreased prefrontal glutamatergic function is associated with a reduced astrocyte-related gene expression in treatment-resistant depression
Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain
Targeting Treatment-Resistant Auditory Verbal Hallucinations in Schizophrenia with fMRI-Based Neurofeedback - Exploring Different Cases of Schizophrenia
Robustness osa neurodevelopmental animal model of schizophrenia : combining immune stimulation with glutamatergic insult
Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism
Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia
Treatment-resistant schizophrenia and global cortical atrophy in a patient with Turner Syndrome [Letter]
Robustness of a neurodevelopmental animal model of schizophrenia: combining immune stimulation with glutamatergic insult
Glutamatergic dysfunction in Schizophrenia
Remission of severe, treatment-resistant schizophrenia following adjunctive cannabidiol
Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review
GRIN2A (NR2A): a gene contributing to glutamatergic involvement in schizophrenia
Decreased prefrontal glutamatergic function is associated with a reduced astrocyte-related gene expression in treatment-resistant depression
Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain
Targeting Treatment-Resistant Auditory Verbal Hallucinations in Schizophrenia with fMRI-Based Neurofeedback - Exploring Different Cases of Schizophrenia
Robustness osa neurodevelopmental animal model of schizophrenia : combining immune stimulation with glutamatergic insult
Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism
Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia
Treatment-resistant schizophrenia and global cortical atrophy in a patient with Turner Syndrome [Letter]